Guest essay from Brendan Saloner
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌
Problems viewing this email?
Thursday, May 12, 2022 | The Latest Research, Commentary, And News From Health Affairs
Dear John,

Today's Health Affairs newsletter includes a guest essay from Brendan Saloner, associate professor at Johns Hopkins Bloomberg School of Public Health.
Substance Use Disorder Treatment
Drug overdose deaths in the US have risen relentlessly in recent years, topping more than 100,000 per year in the most recent federal data. This grim milestone has been largely overshadowed by the COVID-19 pandemic.

Yet the pandemic has exacerbated the isolation of many people with substance use disorders (SUDs) and increased the risks of solitary drug use amid an increasingly lethal and unpredictable drug supply.

In this context, improving access to treatment and other health care services is a critical priority.

Past studies have shown that in a given year very few people—perhaps only one in ten—who meet the screening criteria for SUD use any treatment. It is unclear whether use of treatment has increased over time.

Insurance expansions under the Affordable Care Act greatly increased the availability of comprehensive Medicaid or subsidized Marketplace plans.

More recent federal laws, such as the State Opioid Response grants, have funneled resources to state governments to spend on expanding services.

In the May issue of Health Affairs, my colleagues and I look back at the decade from 2010 to 2019 to understand trends in the use of services among people with SUDs.
The National Survey on Drug Use and Health (NSDUH) is an annual cross-sectional survey of noninstitutionalized Americans.

We focused our analysis on people in the NSDUH who reported past-year symptoms of an SUD, such as significant impairment related to the use of drugs or alcohol.

Disappointingly, we find that use of SUD treatment in this population did not significantly improve over the decade.

The lack of progress was broad—use of treatment was largely flat when we looked across racial/ethnic groups, income groups, and types of substance use disorder.

The lone bright spot is that we did find slightly increased use of treatment over the decade among people who had been in contact with the criminal legal system.

By contrast, when we examined the population with SUD we found that they were making progress in other overall metrics of health care access.

For example, there was a substantial decrease in the uninsured rate among people with SUD, largely due to increased Medicaid enrollment. More people with SUD were receiving care in a doctor’s office or clinic.

Among those who did get SUD treatment, they were more likely to report that this treatment was covered by their health insurance rather than relying on either a safety-net program or their own out-of-pocket payment.

Our main takeaway from this study is that increasing utilization of SUD treatment is a persistent and unresolved challenge.

While the past decade brought better insurance coverage and access to care overall for people with SUD, it did not fundamentally change the probability that they would receive treatment—whether in a specialty clinic, an inpatient rehab, or a doctor’s office.

What is needed to meaningfully close the gap in use of treatment?

While our study cannot answer these questions, several ideas are worth considering:

Creating more “on-ramps” to treatment: Our treatment system remains difficult to navigate, especially for people in crisis. A key ingredient in expanding treatment is ensuring that there are points of referral whether they be in primary care, hospital emergency departments, or jails.

Investing in the workforce: There are not enough addiction specialists to meet the current need. Expanding the workforce requires steps such as increasing the number of advanced practice providers and physicians to treat opioid use disorder with medication, training more counselors, and expanding the number of peer-recovery specialists.

Reducing stigma: While the opioid crisis has created more public awareness of addiction, there remains profound stigma against people with SUDs, which can reduce their willingness to seek help. Public campaigns to celebrate recovery and promote more effective treatment may be helpful in reducing stigma.

The past decade created some of the building blocks for a better SUD treatment system, but the promise of better access to care remains largely unfulfilled.

Using the existing financing and organizational framework to build a patient-centered system of SUD care remains a critical challenge for the future.
Brendan Saloner's Reading List

I try to read widely on issues related substance use policy. Here are three of my book recommendations:

Fighting For Space: How a Group of Drug Users Transformed One City’s Struggle with Addiction: In the 1990s, a grassroots movement emerged in the Downtown East area of Vancouver, British Columbia, focused on the health and safety of people who used drugs. Travis Lupick tells the extraordinary story of community organizing that led to Canada’s first safe-consumption site.

Addicts Who Survived: An Oral History of Narcotic Use in America, 1923-1965: The word “addict” itself has fallen out of favor since this book was published in 1989, but the stories in this book by David Courtwright, Herman Joseph, and Don Des Jarlais provide an invaluable window into the struggles and stories of people who used drugs during an extremely prohibitionist period in the US, and has many intriguing connections to current struggles.

The Opioid Epidemic: What Everyone Needs to Know: This book is a wholly accessible overview of some of the major issues related to the opioid epidemic. Josh Sharfstein and Yngvild Olsen do a magnificent job of connecting history, politics, medicine, and public health into a book you can easily read on a cross-country flight.
Halfway Around The World, Echoes Of Physician Moral Injury

A physician seeks respite from the injustice of US care delivery but encounters familiar signals of system failure abroad.

Elsewhere At Health Affairs
Today in Health Affairs Forefront, Bobby Milstein and coauthors discuss how amid nationwide calls to end systemic racism and other forms of injustice, a new survey finds that only a small fraction of organizational leaders prioritize equitable investment.

Elevating Voices: Asian American and Pacific Islander American Heritage Month: In their Health Affairs Forefront article, Rohan Khazanchi and coauthors call for state and federal policy makers to be intentional about advancing pharmacoequity.
Daily Digest
 
Facebook
 
Twitter
 
Linkedin
 
Youtube
 
Email
About Health Affairs

Health Affairs is the leading peer-reviewed journal at the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online. Late-breaking content is also found through healthaffairs.org, Health Affairs Today, and Health Affairs Sunday Update.  

Project HOPE is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.
Health Affairs, 1220 19th Street, NW, Suite 800, Washington, DC 20036, United States

Privacy Policy

To unsubscribe from this email, update your email preferences here
.